Lower hospitalization rates - even with heart failure - Medizinonline

The results of a pre-specified exploratory analysis of the DANFLU-2 study indicate that the administration of a high-dose inactivated influenza vaccine could provide additional protection in patients with cardiovascular disease. The DANFLU-2 study was conducted in Denmark in the period 2022-2025 over three consecutive influenza seasons.

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten

Already a member? Log in here

Autoren

Mirjam Peter, M.Sc.

Publikation

HAUSARZT PRAXIS
InFo PNEUMOLOGIE & ALLERGOLOGIE

Related Topics

Previous Article

From statins to metformin

Preventive pharmacology and longevity

Oncology

Study updates from the ESMO Congress

You May Also Like

4 min

Preclinical Study on a Special Ginkgo biloba Extract

What role do proanthocyanidins play?

6 min

Myasthenia gravis: immunomodulatory therapies for long-term treatment

Expanded Possibilities Thanks to Innovative Classes of Active Ingredients

7 min

Plastic surgery and reconstructive microsurgery for DFS

Functional limb preservation between infection control, vascular medicine and resurfacing

10 min

Interstitial Lung Diseases

Update on Idiopathic Pulmonary Fibrosis

7 min

Ischemic stroke: Are smaller or larger brain arteries affected?

Recent study findings on intravenous lysis therapy with fibrinolytic agents

7 min

Interview

“On par with the gold standards for trauma”

5 min

Psychology: Emotional Freedom Techniques (EFT)

Emotional Healing Through Tapping

5 min

Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer?

Treat-to-Target – Consensus Recommendations for GC Tapering and the Use of DMARDs

Input your search keywords and press Enter.